114 related articles for article (PubMed ID: 8850404)
1. Gabexate mesilate, a new synthetic serine protease inhibitor: a pilot clinical trial in valvular heart surgery.
Parodi F; Cordero G; De Gasperis C; Minola P; Dellora C; Innocenti P
J Cardiothorac Vasc Anesth; 1996 Feb; 10(2):235-7. PubMed ID: 8850404
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver.
Kim YI; Hwang YJ; Song KE; Yun YK; Lee JW; Chun BY
J Am Coll Surg; 2002 Jul; 195(1):41-50. PubMed ID: 12113544
[TBL] [Abstract][Full Text] [Related]
3. Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats.
Taoka Y; Okajima K; Uchiba M; Murakami K; Kushimoto S; Johno M; Naruo M; Okabe H; Takatsuki K
Crit Care Med; 1997 May; 25(5):874-9. PubMed ID: 9187610
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
5. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
Harada N; Okajima K; Kushimoto S
Crit Care Med; 1999 Sep; 27(9):1958-64. PubMed ID: 10507625
[TBL] [Abstract][Full Text] [Related]
6. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy.
Ono S; Aosasa S; Mochizuki H
Am J Surg; 1999 Jan; 177(1):78-82. PubMed ID: 10037314
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding risk.
Taenaka N; Terada N; Takahashi H; Tachimori Y; Okada T; Takezawa J; Shimada Y; Yoshiya I
Crit Care Med; 1986 May; 14(5):481-3. PubMed ID: 3084171
[TBL] [Abstract][Full Text] [Related]
8. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
[TBL] [Abstract][Full Text] [Related]
9. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver.
Kim YI; Chung HJ; Song KE; Hwang YJ; Lee JW; Lee YJ; Chun BY
Am J Surg; 2006 Jan; 191(1):72-6. PubMed ID: 16399110
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the synthetic proteinase inhibitor, FOY, on hypercoagulability after surgery for esophageal carcinoma].
Usuba A; Motoki R; Koizumi Y; Oishi A; Endo Y; Konno O; Inoue H
Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):931-41. PubMed ID: 2122227
[TBL] [Abstract][Full Text] [Related]
12. Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
Inoue S; Sugitani A; Yamamoto H; Kitada H; Motoyama K; Okabe Y; Ohta M; Yoshida J; Nishiyama K; Tanaka M
Surgery; 2005 Feb; 137(2):216-24. PubMed ID: 15674204
[TBL] [Abstract][Full Text] [Related]
13. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
[TBL] [Abstract][Full Text] [Related]
14. Effects of gabexate mesilate on ischemia-reperfusion-induced testicular injury in rats.
Gezici A; Ozturk H; Buyukbayram H; Ozturk H; Okur H
Pediatr Surg Int; 2006 May; 22(5):435-41. PubMed ID: 16557390
[TBL] [Abstract][Full Text] [Related]
15. [Gabexate mesilate (FOY), a new synthetic protease inhibitor, in the treatment of shock. An Italian multicenter study].
Novelli GP; Innocenti P; Livi P
Minerva Anestesiol; 1993 May; 59(5):247-53. PubMed ID: 8355865
[TBL] [Abstract][Full Text] [Related]
16. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
Chen HM; Chen JC; Hwang TL; Jan YY; Chen MF
Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900
[TBL] [Abstract][Full Text] [Related]
17. Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
Mikami K; Goto T; Miura K; Ohshima S; Yoneyama K; Lin JG; Watanabe D; Segawa D; Kataoka E; Shibuya T; Watanabe S
J Gastroenterol; 2005 Mar; 40(3):260-5. PubMed ID: 15830285
[TBL] [Abstract][Full Text] [Related]
18. Gabexate mesilate (Foy) as an anticoagulant in extracorporeal circulation in dogs and sheep.
Oedekoven B; Bey R; Mottaghy K; Schmid-Schönbein H
Thromb Haemost; 1984 Dec; 52(3):329-32. PubMed ID: 6442472
[TBL] [Abstract][Full Text] [Related]
19. [Gabexate mesilate vs gabexate mesilate combined with octreotide in the prevention of postoperative complications of pancreatic surgery: preliminary results].
Bonora A; Bassi C; Falconi M; Sartori N; De Santis L; Dragonetti C; Innocenti P; Pederzoli P
Chir Ital; 2001; 53(1):65-72. PubMed ID: 11280830
[TBL] [Abstract][Full Text] [Related]
20. Successful intermittent application of the Pringle maneuver for 30 minutes during human hepatectomy: a clinical randomized study with use of a protease inhibitor.
Kim YI; Fujita S; Hwang YJ; Chun JM; Song KE; Chun BY
Hepatogastroenterology; 2007; 54(79):2055-60. PubMed ID: 18251159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
